SEC Filing Summary: Bond Laboratories, Inc. (10-K)
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2008, for Bond Laboratories, Inc. (trading symbol BNLB.OB). The Company is a small business issuer focused on developing and marketing fortified foods and beverages, specifically in the energy, pain relief, and weight loss categories. Key subsidiaries include Fusion Premium Energy, Inc. (launched the "Fusion 6+ Hour Energy Boost" shot) and NDS Nutritional Products, Inc., which was acquired via an Asset Purchase Agreement on October 1, 2008. The acquisition added significant SKUs in sports nutrition and weight loss, with distribution through GNC and other retailers.
Key Financial Metrics
| Metric | 2008 | 2007 |
|---|---|---|
| Revenue | $2,530,424 | $11,531 |
| Cost of Goods Sold | $1,617,503 | $7,845 |
| Gross Profit | $912,921 | $3,685 |
| Operating Expenses | $7,574,830 | $3,935,358 |
| Net Loss | $(6,625,991) | $(3,961,602) |
| Net Loss Per Share (Basic) | $(0.28) | $(0.43) |
| Total Assets | $5,361,707 | $1,314,960 |
| Total Liabilities | $2,293,296 | $30,253 |
| Working Capital | $781,597 | $1,189,303 |
| Cash and Equivalents | $263,379 | $590,197 |
Liquidity & Debt: The Company raised approximately $4.3 million in equity financing during 2008. Total notes payable increased to $1.05 million, primarily related to the NDS acquisition. Cash used in operating activities was $4.75 million, while cash provided by financing activities was $6.26 million.
Material Changes vs. Prior Period
- Revenue Surge: Revenue increased nearly 21,800% from 2007 to 2008, driven by the commercial launch of Fusion energy shots and the Q4 acquisition of NDS Nutritional Products.
- Expense Growth: Operating expenses nearly doubled, with Selling and Marketing expenses rising from $197,736 to $3.1 million. This included approximately $1 million in cash and stock-based sponsorships for extreme sports athletes.
- Asset Base: Total assets quadrupled due to the acquisition of NDS, which added $2.19 million in goodwill and intangible assets, and a significant inventory buildup ($1.98 million) to support sales.
- Stock Activity: The Company issued 4.3 million shares for cash and 1.55 million shares as consideration for the NDS acquisition. A 2-for-1 stock split occurred in early 2008.
Guidance, Outlook, and Risks
Management Commentary: Management attributes the 2008 net loss largely to non-recurring expenses totaling $4.4 million (over 55% non-cash stock-based compensation). Excluding these, the adjusted loss would be approximately $2.2 million. Management projects breakeven in 2009 based on conservative sales projections and cost reductions.
Outlook: The Company plans to shift marketing spend from athlete sponsorships to "in-store" displays in 2009. They aim to leverage the economic downturn to negotiate better supplier terms and acquire talent.
Risks & Contingencies:
- Liquidity: Monthly cash requirements are approximately $125,000. The stock trades on the OTCBB with limited liquidity and is subject to "penny stock" regulations.
- Internal Controls: The Company lacks an independent audit committee and has noted a lack of segregation of duties due to a small staff, though management deems the risk low.
- Competition: The energy drink market is highly competitive with major players like Red Bull and Monster. The Company relies on a niche "energy shot" format.
- Related Party: The CEO has deferred $280,000 in salary, and the Company has a $250,000 promissory note with Vespa Beverages, Inc.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of Q4 2008 revenue ($1.39 million) which was heavily influenced by the NDS acquisition.
- Non-Recurring Costs: Assess the validity of excluding $4.4 million in expenses to calculate "adjusted" losses, specifically the stock-based compensation for services.
- Inventory Valuation: Confirm the realizability of the $1.98 million inventory balance given the competitive market and economic conditions.
- Debt Obligations: Review the repayment schedule for the $1.05 million in notes payable, particularly the secured notes related to the NDS acquisition.
- Stock Dilution: Monitor the impact of 6.36 million outstanding warrants and subscribed shares on future equity value.